Efficacy and toxicity of mitomycin, ifosfamide, and cisplatin (MIP) in patients with inoperable non-small cell lung cancer

Lung Cancer

Volumn 14, Issue 1, 1996, Pages 109-117

  Urban, Thierry ^a   Bedin, Arnaud ^a   Baud, Mariette ^a   Chouaid, Christos ^a   Febvre, Michel ^a   Lebeau, Bernard ^a  

^a HÔPITAL SAINT ANTOINE   (France)

Author keywords

Advanced non small cell lung cancer; Chemotherapy; Efficacy; Toxicity

Indexed keywords

CISPLATIN; IFOSFAMIDE; MITOMYCIN;

ADULT; AGED; ANEMIA; ARTICLE; BRAIN DISEASE; CARDIOTOXICITY; CLINICAL TRIAL; FEMALE; HUMAN; KIDNEY FAILURE; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; NEUTROPENIA; PERIPHERAL NEUROPATHY; PNEUMONIA; PRIORITY JOURNAL; SURVIVAL;

EID: 0029982051     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/0169-5002(95)00516-1     Document Type: Article

References (22)

1. Artal A, Vicent JM, Vadell C et al. Study of combination MIC (mitomycin, ifosfamide and etoposide) in unresectable or advanced NSCLC as standard treatment. A multicentric study. Proc IASLC 1994; 11(suppl. 1): abstract 480.
2. Cellerino R, Tumarrello D, Piga A. Chemotherapy or not in advanced non-small cell lung cancer. Lung Cancer 1990; 6: 99-109.
3. Cellerino R, Tummarello D Guidi F et al. A randomized trial of alternating chemotherapy versus best supportive care in advanced non-small cell lung cancer. J Clin Oncol 1991; 9: 1453-1461.
4. Cormier Y, Bergeron D, La Forge J et al. Benefits of polychemotherapy in advanced non-small cell oncogenic carcinoma. Cancer 1982; 50: 845-849.
5. Crino L, Clerici M, Figoli F et al. Superiority of three-drug combination chemotherapy versus cisplatin-etoposide in advanced non-small cell lung cancer. A randomized trial of the Italian Oncology Group for Clinical Research. Proc. IASLC 1994; 11(suppl. 1): abstract 472.
6. Cullen MC, Yoshi R, Chetiyawardana AM, Woodroffe CM. Mitomycin, ifosfamide and cisplatin in non-small cell lung cancer. Treatment good enough to compare. Br J Cancer 1988; 58: 359-361.
7. Depierre A, Lemarie E, Dabouis G, Garnier G, Jacoulet P, Dalphin JC. A phase II study of navelbine (vinorelbine) in the treatment of non-small cell lung cancer. Am J Clin Oncol 1991; 14: 115-119.
8. Depierre A, Milleron B, Chastang CI, Lebeau B et al. Phase III randomized study of neoadjuvant chemotherapy with surgery in non-small cell lung cancer. Fourth international Congress on Anti-Cancer Chemotherapy, Paris, 1993.
9. Donnadieu N, Paesmans M, Sculier JP. Chemotherapy of non-small cell lung cancer according to disease extent. A meta-analysis of the literature. Lung Cancer 1991; 7: 243-252.
10. Eberhardt W, Niederle N. Ifosfamide in non-small cell lung cancer: a review. Semin Oncol 1992; 19: 40-48.
11. Ganz PA, Figlin RA, Haskell CM, La Soto N, Siau B. Supportive care versus supportive care and combination chemotherapy in metastatic non-small cell lung cancer: does chemotherapy make a difference? Cancer 1989; 63: 1271-1278.
12. Gatzemeier U. Mitomycin-C in non-small cell lung cancer. In: Tetsuo Taguchi, Karl Aigner, editors. Mitomycin C in cancer chemotherapy. Exerpta Medica, 1991; 27-39.
13. Giron CC, Ordonez A, Jalon JI, Baron MG. Combination chemotherapy with ifosfamide, mitomycin and cisplatin in advanced non-small cell lung cancer. Cancer Treat Rep 1987; 71: 851-853.
14. Ihde DC, Minna JD. Non-small cell lung cancer. I: Biology, diagnosis, and staging. II: Treatment. Curr Probl Cancer 1991; 15: 61-154.
15. Maki E, Feld R. Prognostic factors in patients with non-small cell lung cancer. A critique of the world literature. Lung Cancer 1991; 7: 27-34.
16. Milew DW, Earl HM, Drake J et al. Combination chemotherapy with mitomycin, ifosfamide and cisplatin in non-small cell lung cancer. Br J Cancer 1990; 61: 183.
17. Quoix E, Dietemann A, Charbonneau J et al. Disseminated non-small cell lung cancer. A randomized trial of chemotherapy versus palliative care. Lung Cancer 1988; 4(suppl.): A127.
18. Rapp E, Pater JL, Willan A et al. Chemotherapy can prolonge survival in patients with advanced non-small-cell lung cancer - report of a Canadian multicenter randomized trial. J Clin Oncol 1988; 6: 633-641.
19. Rosell R, Gomez-Codina J, Camps C et al. A randomized trial comparing preoperative chemotherapy plus surgery versus surgery alone in non-small-cell-lung-cancer. N Engl J Med 1994; 330: 153-158.
20. Souquet PJ, Chauvin F, Boissel JP et al. Polychemotherapy in advanced non-small cell lung cancer: a meta-analysis. Lancet 1993; 342: 19-21.
21. Woods RL, Williams DJ, Levi J et al. A randomized trial of cisplatin and vindesine versus supportive care only in advanced non-small cell lung cancer. Br J Cancer 1990; 61: 608-611.
22. World Health Organization. The Wold Health Organization histological typing of lung tumors, 2nd edn. Am J Clin Pathol 1982; 77: 123-136.